Transdermal oestrogene application a contraindication in therapy of endometriosis with Gonadotropin-Releasing Hormon analogues

Use of a gonadotropin-releasing hormone

Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus

✍ Emily C. Somers; Wendy Marder; Gregory M. Christman; Vladimir Ognenovski; W. Jos 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## Abstract ## Objective Cyclophosphamide (CYC) therapy for systemic lupus erythematosus (SLE), a disease predominantly affecting women of childbearing age, causes an unacceptably high incidence of irreversible premature ovarian failure (POF). This study was performed to evaluate the effectiveness